SCHEMBL6586419

SCHEMBL6586419

[CH2]C1CC1c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR2B P41595 1/20 0.50
SLC6A3 Q01959 5/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
MDM2 Q00987 1/20 0.42
SLC9A1 P19634 1/20 0.42
LMNA P02545 1/20 0.40
CYP2A6 P11509 1/20 0.40
KDM1A O60341 3/20 0.38
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
HTR3A P46098 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27288656 0.81 MDM2 (0.43) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL31113844 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL7509163 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL27298262 0.75 HTR2A (0.50) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL7509170 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL6991920 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL2837243 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL6991918 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL16591166 0.75 HTR2A (0.50) HTR2AHTR2CHTR2BSLC6A3SLC6A2
SCHEMBL2835482 0.75 KDM1A (0.60) HTR2AHTR2CHTR2BSLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104039753-A Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS INC 2014-09-10 CN disclosed
EP-1390354-A1 TRIAZINYL ACRYLAMIDE DERIVATIVES AS KINASE INHIBITORS Amgen Inc. (US) 2004-02-25 EP disclosed
WO-2002083653-A1 TRIAZINYL ACRYLAMIDE DERIVATIVES AS KINASE INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed